Data protection Impressum

Neuroscience

Geneva's Neurosoft Bioelectronics has raised USD 7.5 million in an oversubscribed seed round to advance its brain interface platform and build a cortical AI model.

Neurosoft Bioelectronics raises USD 7.5 million to advance its brain interface platform

26 May 2026

ONWARD Medical has secured EUR 40.6 million through an accelerated bookbuild offering led by a EUR 25 million investment from EQT Life Sciences, extending the company's cash runway into the first quarter of 2028.

ONWARD Medical raises EUR 40 million to extend ARC therapy commercialization

20 April 2026

Geneva-based Clee Medical has raised Seed funding to accelerate clinical validation of its Neuro Access imaging technology for minimally invasive neurosurgery.

Clee Medical secures financing to advance real-time brain imaging platform

25 February 2026

Geneva has inaugurated its first AI health hub at Campus Biotech to advance AI-driven care, research and neurotechnology in Western Switzerland.

Geneva inaugurates its first AI health hub at Campus Biotech

8 December 2025

Neurotechnology company ONWARD Medical extends its cash runway through 2026 and prepares to expand commercialization and clinical development of its ARC Therapy systems.

ONWARD Medical raises over EUR 50 million to advance spinal cord therapies

27 October 2025

Geneva-based biotech Stalicla secures funding to advance precision medicine programs for autism and substance use disorders.

Addex Therapeutics leads CHF 2 million investment in Stalicla

14 July 2025

Superlab Suisse will open a new laboratory at Campus Biotech in Geneva in January 2026, strengthening the region’s innovation infrastructure for life sciences start-ups.

Superlab expands to Geneva with new lab at Campus Biotech

25 June 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (March 2025)

26 March 2025

Geneva has unveiled its new Innovation Master Plan 2025-2027 (“Plan Directeur de l’Innovation 2025-2027” in French), designed to consolidate the canton’s position as a leading international innovation hub. Backed by CHF 11 million in public investment, the strategy focuses on infrastructure enhancement, targeted financing, and fostering entrepreneurship to bolster Geneva’s economic strength.

Geneva strengthens its innovation ecosystem with a strategic development plan

10 March 2025

Geneva-based Neurosoft Bioelectronics has set a new benchmark in neurotechnology with its high-resolution, stretchable brain interface for epilepsy monitoring. The EPFL spin-off successfully tested its device on two human patients, paving the way for broader clinical applications.

Neurosoft Bioelectronics advances brain interface technology for epilepsy and tinnitus

5 March 2025

1 2